
James Martinell
Examiner (ID: 6933, Phone: (571)272-0719 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1207, 1631, 1803, 1634, 1804, 1633, 1802, 1805, 1302 |
| Total Applications | 2308 |
| Issued Applications | 1281 |
| Pending Applications | 221 |
| Abandoned Applications | 809 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7729641
[patent_doc_number] => 08101577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-24
[patent_title] => 'Oxidative DNA damage protection'
[patent_app_type] => utility
[patent_app_number] => 12/502750
[patent_app_country] => US
[patent_app_date] => 2009-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 21
[patent_no_of_words] => 21531
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/101/08101577.pdf
[firstpage_image] =>[orig_patent_app_number] => 12502750
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/502750 | Oxidative DNA damage protection | Jul 13, 2009 | Issued |
Array
(
[id] => 6543010
[patent_doc_number] => 20100125042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-20
[patent_title] => 'PERIPHERAL GENE EXPRESSION BIOMARKERS FOR AUTISM'
[patent_app_type] => utility
[patent_app_number] => 12/467115
[patent_app_country] => US
[patent_app_date] => 2009-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 27743
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20100125042.pdf
[firstpage_image] =>[orig_patent_app_number] => 12467115
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/467115 | Peripheral gene expression biomarkers for autism | May 14, 2009 | Issued |
Array
(
[id] => 6607014
[patent_doc_number] => 20100099093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'Biomarkers for the Identification Monitoring and Treatment of Head and Neck Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/466291
[patent_app_country] => US
[patent_app_date] => 2009-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 40188
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099093.pdf
[firstpage_image] =>[orig_patent_app_number] => 12466291
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/466291 | Biomarkers for the Identification Monitoring and Treatment of Head and Neck Cancer | May 13, 2009 | Abandoned |
Array
(
[id] => 6390972
[patent_doc_number] => 20100083407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-01
[patent_title] => 'NUCLEOTIDE SEQUENCES AND POLYPEPTIDES ENCODED THEREBY USEFUL FOR MODIFYING PLANT CHARACTERISTICS'
[patent_app_type] => utility
[patent_app_number] => 12/435281
[patent_app_country] => US
[patent_app_date] => 2009-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8231
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20100083407.pdf
[firstpage_image] =>[orig_patent_app_number] => 12435281
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/435281 | NUCLEOTIDE SEQUENCES AND POLYPEPTIDES ENCODED THEREBY USEFUL FOR MODIFYING PLANT CHARACTERISTICS | May 3, 2009 | Abandoned |
Array
(
[id] => 5570397
[patent_doc_number] => 20090253775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'Compositions and Methods for Therapy and Diagnosis of Cancer and Cancer Metastasis'
[patent_app_type] => utility
[patent_app_number] => 12/420612
[patent_app_country] => US
[patent_app_date] => 2009-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 22161
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20090253775.pdf
[firstpage_image] =>[orig_patent_app_number] => 12420612
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/420612 | Compositions and Methods for Therapy and Diagnosis of Cancer and Cancer Metastasis | Apr 7, 2009 | Abandoned |
Array
(
[id] => 8016835
[patent_doc_number] => 08137919
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-20
[patent_title] => 'Method of determining the sensitivity of cancer cells to EGFR inhibitors including cetuximab, panitumumab and erlotinib'
[patent_app_type] => utility
[patent_app_number] => 12/384826
[patent_app_country] => US
[patent_app_date] => 2009-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 4063
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/137/08137919.pdf
[firstpage_image] =>[orig_patent_app_number] => 12384826
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/384826 | Method of determining the sensitivity of cancer cells to EGFR inhibitors including cetuximab, panitumumab and erlotinib | Apr 7, 2009 | Issued |
Array
(
[id] => 8807556
[patent_doc_number] => 08445207
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-21
[patent_title] => 'Genes based on thalidomide, valproic acid and methotrexate treatment for screening of drug inducing teratogenicity and screening method using thereof'
[patent_app_type] => utility
[patent_app_number] => 12/419758
[patent_app_country] => US
[patent_app_date] => 2009-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 22039
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12419758
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/419758 | Genes based on thalidomide, valproic acid and methotrexate treatment for screening of drug inducing teratogenicity and screening method using thereof | Apr 6, 2009 | Issued |
Array
(
[id] => 5315893
[patent_doc_number] => 20090280491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'PREDICTING CANCER INVASIVENESS'
[patent_app_type] => utility
[patent_app_number] => 12/412164
[patent_app_country] => US
[patent_app_date] => 2009-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5680
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20090280491.pdf
[firstpage_image] =>[orig_patent_app_number] => 12412164
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/412164 | PREDICTING CANCER INVASIVENESS | Mar 25, 2009 | Abandoned |
Array
(
[id] => 5495383
[patent_doc_number] => 20090263411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'Compositions, splice variants and methods relating to ovarian specific genes and proteins'
[patent_app_type] => utility
[patent_app_number] => 12/383449
[patent_app_country] => US
[patent_app_date] => 2009-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 122345
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20090263411.pdf
[firstpage_image] =>[orig_patent_app_number] => 12383449
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/383449 | Compositions, splice variants and methods relating to ovarian specific genes and proteins | Mar 23, 2009 | Issued |
Array
(
[id] => 5495782
[patent_doc_number] => 20090263810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'BISULFITE CONVERSION OF DNA'
[patent_app_type] => utility
[patent_app_number] => 12/410389
[patent_app_country] => US
[patent_app_date] => 2009-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7925
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20090263810.pdf
[firstpage_image] =>[orig_patent_app_number] => 12410389
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/410389 | Bisulfite conversion of DNA | Mar 23, 2009 | Issued |
Array
(
[id] => 6294835
[patent_doc_number] => 20100240101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'Parallel Proximity Ligation Event Analysis'
[patent_app_type] => utility
[patent_app_number] => 12/407547
[patent_app_country] => US
[patent_app_date] => 2009-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 24231
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20100240101.pdf
[firstpage_image] =>[orig_patent_app_number] => 12407547
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/407547 | Parallel proximity ligation event analysis | Mar 18, 2009 | Issued |
Array
(
[id] => 7987579
[patent_doc_number] => 08076084
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-13
[patent_title] => 'Method of predicting metastatic potential prognosis or overall survival of cancer patients'
[patent_app_type] => utility
[patent_app_number] => 12/406379
[patent_app_country] => US
[patent_app_date] => 2009-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 3931
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/076/08076084.pdf
[firstpage_image] =>[orig_patent_app_number] => 12406379
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/406379 | Method of predicting metastatic potential prognosis or overall survival of cancer patients | Mar 17, 2009 | Issued |
Array
(
[id] => 6542077
[patent_doc_number] => 20100287671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'Stress-regulated genes of plants, transgenic plants containing same, and methods of use'
[patent_app_type] => utility
[patent_app_number] => 12/383067
[patent_app_country] => US
[patent_app_date] => 2009-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60462
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20100287671.pdf
[firstpage_image] =>[orig_patent_app_number] => 12383067
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/383067 | Stress-regulated genes of plants, transgenic plants containing same, and methods of use | Mar 17, 2009 | Issued |
Array
(
[id] => 7555277
[patent_doc_number] => 08067178
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-29
[patent_title] => 'Gene expression markers for prediction of patient response to chemotherapy'
[patent_app_type] => utility
[patent_app_number] => 12/404268
[patent_app_country] => US
[patent_app_date] => 2009-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57965
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/067/08067178.pdf
[firstpage_image] =>[orig_patent_app_number] => 12404268
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/404268 | Gene expression markers for prediction of patient response to chemotherapy | Mar 12, 2009 | Issued |
Array
(
[id] => 5379727
[patent_doc_number] => 20090191566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'Kits for Isolating Nucleic Acids Using Multifunctional Group-Coated Solid Phase Carriers'
[patent_app_type] => utility
[patent_app_number] => 12/396586
[patent_app_country] => US
[patent_app_date] => 2009-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 21043
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20090191566.pdf
[firstpage_image] =>[orig_patent_app_number] => 12396586
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/396586 | Kits for Isolating Nucleic Acids Using Multifunctional Group-Coated Solid Phase Carriers | Mar 2, 2009 | Abandoned |
Array
(
[id] => 6642456
[patent_doc_number] => 20100005550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'Nucleic acid sequences from Chlorella sarokiniana and Uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/368174
[patent_app_country] => US
[patent_app_date] => 2009-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 127728
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20100005550.pdf
[firstpage_image] =>[orig_patent_app_number] => 12368174
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/368174 | Nucleic acid sequences from Chlorella sarokiniana and Uses thereof | Feb 8, 2009 | Abandoned |
Array
(
[id] => 7586763
[patent_doc_number] => 20110281273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'METHOD OF MAKING DNA TAG'
[patent_app_type] => utility
[patent_app_number] => 13/147128
[patent_app_country] => US
[patent_app_date] => 2009-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12832
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281273.pdf
[firstpage_image] =>[orig_patent_app_number] => 13147128
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/147128 | Method of making DNA tag | Jan 28, 2009 | Issued |
Array
(
[id] => 9140046
[patent_doc_number] => 08580503
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-12
[patent_title] => 'Methods and compositions for diagnosing complications of pregnancy'
[patent_app_type] => utility
[patent_app_number] => 12/864424
[patent_app_country] => US
[patent_app_date] => 2009-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12610
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12864424
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/864424 | Methods and compositions for diagnosing complications of pregnancy | Jan 25, 2009 | Issued |
Array
(
[id] => 6118610
[patent_doc_number] => 20110076283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'METHOD FOR PREDICTING AND DIAGNOSING BRAIN TUMOR'
[patent_app_type] => utility
[patent_app_number] => 12/864278
[patent_app_country] => US
[patent_app_date] => 2009-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 20538
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20110076283.pdf
[firstpage_image] =>[orig_patent_app_number] => 12864278
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/864278 | METHOD FOR PREDICTING AND DIAGNOSING BRAIN TUMOR | Jan 22, 2009 | Abandoned |
Array
(
[id] => 5379718
[patent_doc_number] => 20090191557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'MN/CA IX/CA9 and renal cancer prognosis'
[patent_app_type] => utility
[patent_app_number] => 12/321506
[patent_app_country] => US
[patent_app_date] => 2009-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13267
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20090191557.pdf
[firstpage_image] =>[orig_patent_app_number] => 12321506
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/321506 | MN/CA IX/CA9 and renal cancer prognosis | Jan 21, 2009 | Issued |